Journal of Cancer Genetics and Biomarkers
Cancer genetics and biomarkers are essential in the diagnosis and treatment of cancer. Cancer is a complex and diverse disease, and its diagnosis and treatment require a personalized approach. Cancer genetics and biomarkers play a significant role in identifying the disease's specific characteristics, which makes personalized approaches possible. Cancer genetics deals with the study of genetic mutations that contribute to the development of cancer. The changes or mutations in genes can occur due to genetic factors or external factors such as exposure to carcinogens. These mutations cause cells to grow and divide uncontrollably, leading to the development of cancer. Biomarkers, on the other hand, are molecules or substances that indicate the presence of cancer or the risk of developing it. Biomarkers can be a range of molecules such as proteins, DNA, or RNA. They are used to detect cancer early, monitor its progression, and determine the most appropriate treatment. The Journal of Cancer Genetics and Biomarkers is a platform for publishing research in this field. The journal aims to promote the latest scientific research, methods, and technologies for the diagnosis, treatment, and prevention of cancer. It includes a vast range of research topics from molecular genetics, to the development of new biomarkers, and their clinical applications. In conclusion, cancer genetics and biomarkers are essential in the diagnosis and treatment of cancer. The Journal of Cancer Genetics and Biomarkers provides a platform for researchers and clinicians to share their findings, which can lead to the development of more personalized and effective therapies for cancer patients.
← Journal of Cancer Genetics And Biomarkers